Genpact Limited (NYSE:G) Short Interest Up 31.2% in March

Genpact Limited (NYSE:GGet Free Report) was the recipient of a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 4,420,000 shares, a growth of 31.2% from the March 15th total of 3,370,000 shares. Currently, 2.5% of the company’s shares are sold short. Based on an average daily trading volume, of 1,560,000 shares, the short-interest ratio is presently 2.8 days.

Wall Street Analysts Forecast Growth

G has been the topic of a number of analyst reports. Citigroup increased their price target on Genpact from $35.00 to $36.00 and gave the company a “neutral” rating in a research note on Wednesday, January 17th. JPMorgan Chase & Co. raised their price objective on Genpact from $42.00 to $43.00 and gave the stock an “underweight” rating in a research note on Friday, February 9th. StockNews.com cut Genpact from a “strong-buy” rating to a “buy” rating in a research report on Friday, April 5th. Needham & Company LLC restated a “buy” rating and issued a $40.00 target price on shares of Genpact in a research note on Friday, February 9th. Finally, Mizuho initiated coverage on Genpact in a research note on Tuesday, January 30th. They issued a “neutral” rating and a $40.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $40.11.

Get Our Latest Stock Report on G

Genpact Stock Down 1.7 %

G stock opened at $31.21 on Monday. The company has a current ratio of 1.44, a quick ratio of 1.44 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $5.63 billion, a PE ratio of 9.10, a PEG ratio of 1.47 and a beta of 1.07. Genpact has a 1-year low of $29.41 and a 1-year high of $45.99. The business’s 50 day simple moving average is $33.94 and its 200 day simple moving average is $34.44.

Genpact (NYSE:GGet Free Report) last released its quarterly earnings results on Thursday, February 8th. The business services provider reported $0.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.65 by $0.03. The business had revenue of $1.15 billion during the quarter, compared to the consensus estimate of $1.12 billion. Genpact had a return on equity of 23.19% and a net margin of 14.10%. As a group, research analysts anticipate that Genpact will post 2.7 EPS for the current year.

Genpact Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 26th. Stockholders of record on Monday, March 11th were given a dividend of $0.153 per share. This represents a $0.61 dividend on an annualized basis and a dividend yield of 1.96%. This is an increase from Genpact’s previous quarterly dividend of $0.14. The ex-dividend date of this dividend was Friday, March 8th. Genpact’s dividend payout ratio is presently 17.78%.

Insider Activity

In other news, SVP Heather White sold 11,450 shares of the stock in a transaction on Monday, January 22nd. The stock was sold at an average price of $36.00, for a total value of $412,200.00. Following the transaction, the senior vice president now owns 21,175 shares of the company’s stock, valued at approximately $762,300. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 2.80% of the stock is currently owned by company insiders.

Institutional Trading of Genpact

A number of institutional investors have recently modified their holdings of the stock. Neuberger Berman Group LLC lifted its position in shares of Genpact by 2.2% during the 1st quarter. Neuberger Berman Group LLC now owns 12,165 shares of the business services provider’s stock worth $529,000 after buying an additional 258 shares during the last quarter. Pathstone Family Office LLC lifted its position in shares of Genpact by 1.8% during the 4th quarter. Pathstone Family Office LLC now owns 15,076 shares of the business services provider’s stock worth $697,000 after buying an additional 265 shares during the last quarter. American Trust lifted its position in shares of Genpact by 2.8% during the 4th quarter. American Trust now owns 10,888 shares of the business services provider’s stock worth $504,000 after buying an additional 298 shares during the last quarter. Belpointe Asset Management LLC lifted its position in shares of Genpact by 27.6% during the 1st quarter. Belpointe Asset Management LLC now owns 1,446 shares of the business services provider’s stock worth $67,000 after buying an additional 313 shares during the last quarter. Finally, Cresset Asset Management LLC lifted its position in shares of Genpact by 6.1% during the 1st quarter. Cresset Asset Management LLC now owns 5,645 shares of the business services provider’s stock worth $246,000 after buying an additional 326 shares during the last quarter. 96.03% of the stock is currently owned by institutional investors.

About Genpact

(Get Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Recommended Stories

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.